NCT01165684 Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen Status COMPLETED Phase PHASE4
NCT01162876 A Clinical Pharmacology Study of Saxagliptin in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT01160991 Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism Status COMPLETED Phase NA
NCT01156116 Effective Treatment of Sleep Apnea in Prediabetes to Reduce Cardiometabolic Risk Status COMPLETED Phase NA
NCT01155206 Acute Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Status COMPLETED Phase PHASE4
NCT01154881 A Trial Evaluating the Blood Glucose-lowering Effect of NN1250 in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01153243 Vitamin D and Inflammatory Markers of Cardiovascular Disease in African Americans With Type 2 Diabetes Status UNKNOWN Phase PHASE4
NCT01153100 Effectiveness of Adding Subcutaneous Long-acting Glargine to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy Status COMPLETED Phase PHASE1
NCT01152957 Miami Healthy Heart Initiative a Behavioral Study on Cardiovascular Risk Factors Status COMPLETED Phase NA
NCT01152372 Experimental Study to Validate the Modified Glucose Disposal Test Status COMPLETED Phase PHASE1
NCT01152242 Pharmacodynamic and Pharmacokinetic Variability of a Basal Insulin (0000-168) Status COMPLETED Phase PHASE1
NCT01151072 A Trial Comparing the Effect of NN1250 After Different Routes of Injection in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01147276 Vildagliptin and the Glucagon Response to Hypoglycemia in Type 1 Diabetes Status COMPLETED Phase PHASE4
NCT01145534 Evaluation of Cissus Verticillata L. Infusion in Controlling Type 2 Diabetes Status COMPLETED Phase PHASE1/PHASE2
NCT01145066 Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects Status COMPLETED Phase PHASE2